Prognostic implication of telomerase activity in patients with brain tumors

Journal of Korean Medical Science

Volumn 21, Issue 1, 2006, Pages 126-130

  Kim, Choong Hyun ^a,b   Cheong, Jin Hwan ^a   Bak, Koang Hum ^a   Kim, Jae Min ^a   Oh, Suck Jun ^a  

^a Hanyang University   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

Brain Neoplasms; Glioma; Survival; Telomerase

Indexed keywords

EID: 33144460236     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.1.126     Document Type: Article

References (24)

1. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-73.
2. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994; 91:2882-5.
3. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998; 95:90-2.
4. Harley CB, Futcher AB, Geider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-60.
5. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science 1997; 275:973-7.
6. Hanh WC. New functions for telomerase. Cancer Res Treat 2003; 35:467-71.
7. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405-13.
8. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrieh SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
9. Falchetti ML, Larocca LM, Pallini R. Telomerase in brain tumors. Childs Nerv Syst 2002; 18:112-7.
10. Hiraga S, Ohnishi T, Izuinoto S, Miyahara E, Kanemura Y, Matsumura H, Arita N. Telomerase activity and alterations in telomere length in human brain tumors. Cancer Res 1998; 58:2117-25.
11. Yoshino A, Katayama Y, Fukushima T, Watanabe T, Komine C, Yokoyama T, Kusama K, Moro I. Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence. J Neurooncol 2003; 63:155-62.
12. Holt SE, Glinsky VV, Ivanova AB, Glinsky GV. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol Cardnog 1999; 25:241-8.
13. Kepes JJ. Review of the WHO's proposed new classification of brain tumors. Proceedings of the XIth International Congress of Neuropathology, Kyoto, September 2-8, 1990. Japanese Society of Neuropathology, Kyoto, Japan.
14. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB, Robinson MO. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997; 11: 3109-15.
15. Harada K, Kurisu K, Arita K, Sadatomo T, Tahara H, Tahara E, Ide T, Uozumi T. Telomerase activity in central nervous system malignant lymphoma. Cancer 1999; 86:1050-5.
16. Park WC, Jung SS, Kim IC. Diagnostic significance of telomerase activity in breast cancer. J Korean Surg Soc 2000; 58; 767-74.
17. Lee HJ, Myung SJ, Park YH, Cho YK, Jung HY, Lee GH, Hong WS, Yang SK, Kim JH, Min YI. Measurement of telomerase activity and telomerase reverse transcriptase expression in gastric fluid and tissue for early diagnosis of stomach cancer. Korean J Gatroenterol 2003; 42:183-9.
18. Wu TC, Lin P, Hsu CP, Huang YJ, Chen CY, Chung WC, Lee H, Ko JL. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinoma. Lung Cancer 2003; 41:163-9.
19. Okayasu I, Mitomi H, Yamashita K, Mikami T, Fujiwara M, Kato M, Oshimura M. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in cobrectal carcinoma, J Cancer Res Clin Oncol 1998; 124:444-9.
20. Poremba C, Hero B, Heine B, Scheel C, Schaefer KL, Christiansen H, Berthold F, Kneif S, Stein H, Juergens H, Boecker W, Dockhom-Dworniczak B. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 2000; 35:651-5.
21. Kudoh C, Sugiura K, Hisatomi H, Detta A, Yeh J. Detection of telomerase RNA component and telomerase activity in human brain tumors. 49th Annual Meeting of Congress of Neurological Surgeons, Boston, USA, 1999, Abstract p645.
22. Kleinschmidt-DeMasters BK, Shroyer AL, Hashizumi TL, Evans LC, Markham N, Kindt G, Shroyer KR. Part I. Telomerase levels in human metastatic brain tumors four-fold logarithmic variability but no correlation with tumor type or interval to patient demise. J Neurol Sci 1998; 161:116-23.
23. Liao CT, Tung-Chieh Chang J, Wang HM, Chen IH, Lin CY, Chen TM, Hsieh LL, Cheng AJ. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck 2004:26:504-12.
24. Koscielny S, Dahse R, Sonntag J, Riese U, Theuer C, Huffman ME, von Eggeling F, Claussen U, Beleites E, Ernst G, Fiedler W. Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p 16 (CDKN2A) in head and neck cancer. Otolaryngol Pol 2000; 54:291-5.